gabexate has been researched along with Acute Myelogenous Leukemia in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 64-year-old man was diagnosed with acute myeloid leukemia (AML) complicated by disseminated intravascular coagulation." | 1.35 | Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion. ( Aota, Y; Iguchi, T; Kurashige, Y; Miyakura, T; Nagai, A; Tsuboi, R; Yamamoto, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ookura, M | 1 |
| Hosono, N | 1 |
| Tasaki, T | 1 |
| Oiwa, K | 1 |
| Fujita, K | 1 |
| Ito, K | 1 |
| Lee, S | 1 |
| Matsuda, Y | 1 |
| Morita, M | 1 |
| Tai, K | 1 |
| Negoro, E | 1 |
| Kishi, S | 1 |
| Iwasaki, H | 1 |
| Ueda, T | 1 |
| Yamauchi, T | 1 |
| Miyakura, T | 1 |
| Yamamoto, T | 1 |
| Kurashige, Y | 1 |
| Nagai, A | 1 |
| Iguchi, T | 1 |
| Aota, Y | 1 |
| Tsuboi, R | 1 |
2 other studies available for gabexate and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Topics: Adolescent; Aged; Aged, 80 and over; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinog | 2018 |
Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion.
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Extravasation of Diagnostic and Therapeutic | 2008 |